Potassium Chloride is a drug owned by Genus Life Sciences Inc. It is protected by 1 US drug patent filed in 2026 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Mar 07, 2039. Details of Potassium Chloride's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US12539314 | NA |
Mar, 2039
(13 years from now) | Active |
US patents provide insights into the exclusivity only within the United States, but
Potassium Chloride is protected by patents in multiple countries.
Understanding
the full scope
of patent protection is crucial in strategizing market entry. By looking at the broader patent
landscape, you can
identify markets with weaker patent protection which could be ideal generic entry points. The
following section offers
details on Potassium Chloride's family patents as well as insights into
ongoing legal events
on those patents.
Potassium Chloride's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Potassium Chloride's generic launch date based on the expiry of its last outstanding patent is estimated to be Mar 07, 2039 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Potassium Chloride Generic API suppliers:
Potassium Chloride is the generic name for the brand Potassium Chloride. 56 different companies have already filed for the generic of Potassium Chloride, with Fresenius Kabi Usa having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Potassium Chloride's generic
Alternative Brands for Potassium Chloride
There are several other brand drugs using the same active ingredient (Potassium Chloride) as Potassium Chloride. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | ||
|---|---|---|---|
| Alcon Pharms Ltd |
| ||
| Azurity |
| ||
| Braintree |
| ||
| Fresenius Kabi Usa |
| ||
| Salix |
| ||
| Salix Pharms |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Potassium Chloride, Potassium Chloride's active ingredient. Check the complete list of approved generic manufacturers for Potassium Chloride
About Potassium Chloride
Potassium Chloride is a drug owned by Genus Life Sciences Inc. Potassium Chloride uses Potassium Chloride as an active ingredient. Potassium Chloride was launched by Genus in 2025.
Approval Date:
Potassium Chloride was approved by FDA for market use on 25 November, 2025.
Active Ingredient:
Potassium Chloride uses Potassium Chloride as the active ingredient. Check out other Drugs and Companies using Potassium Chloride ingredient
Dosage:
Potassium Chloride is available in solution form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 20MEQ/15ML | SOLUTION | Prescription | ORAL |
| 40MEQ/15ML | SOLUTION | Prescription | ORAL |